233 related articles for article (PubMed ID: 10608165)
21. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
22. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
[TBL] [Abstract][Full Text] [Related]
23. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
Kuhl H; Stevenson J
Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
[TBL] [Abstract][Full Text] [Related]
24. Effects of menopause and estrogen replacement therapy or hormone replacement therapy in women with diabetes mellitus: consensus opinion of The North American Menopause Society.
Menopause; 2000; 7(2):87-95. PubMed ID: 10746890
[TBL] [Abstract][Full Text] [Related]
25. Postmenopausal hormone replacement therapy and major clinical outcomes: a focus on cardiovascular disease, osteoporosis, dementia, and breast and endometrial neoplasia.
Dick SE; DeWitt DE; Anawalt BD
Am J Manag Care; 2002 Jan; 8(1):95-104; quiz 105-6. PubMed ID: 11814176
[TBL] [Abstract][Full Text] [Related]
26. Hormone replacement therapy and cardiovascular disease revisited.
Stevenson JC
Menopause Int; 2009 Jun; 15(2):55-7. PubMed ID: 19465669
[TBL] [Abstract][Full Text] [Related]
27. Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?
Mikkola TS; Clarkson TB; Notelovitz M
Ann Med; 2004; 36(6):402-13. PubMed ID: 15513292
[TBL] [Abstract][Full Text] [Related]
28. Hormone therapy and cardiovascular disease--still much to be learnt.
Mikkola TS; Ylikorkala O
Gynecol Endocrinol; 2005 Feb; 20(2):116-20. PubMed ID: 15823832
[TBL] [Abstract][Full Text] [Related]
29. [Hormonal supplements for postmenopausal women: no evidence of protection against cardiovascular disease].
Stehouwer CD
Ned Tijdschr Geneeskd; 2001 Jan; 145(2):61-4. PubMed ID: 11225257
[TBL] [Abstract][Full Text] [Related]
30. [Hormone replacement therapy and cardiovascular prevention: many statements, some doubts].
Motolese M
Ital Heart J Suppl; 2003 Jul; 4(7):545-58. PubMed ID: 14558283
[TBL] [Abstract][Full Text] [Related]
31. [Postmenopausal hormone replacement and cardiovascular disease].
Oian P; Aune B
Tidsskr Nor Laegeforen; 1993 Jan; 113(2):193-6. PubMed ID: 8430399
[TBL] [Abstract][Full Text] [Related]
32. Hormone replacement therapy in postmenopausal women with diabetes mellitus.
Thijs A; Stehouwer CD
Semin Vasc Med; 2002 May; 2(2):215-9. PubMed ID: 16222612
[TBL] [Abstract][Full Text] [Related]
33. Controversies over hormone replacement therapy. HRT as a risk factor of breast cancer in postmenopausal women.
Licznerska BE; Baer-Dubowska W
Acta Pol Pharm; 2005; 62(3):241-7. PubMed ID: 16193819
[TBL] [Abstract][Full Text] [Related]
34. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
35. [Risks and benefits of postmenopausal hormone replacement therapy].
Szántó F
Orv Hetil; 1998 Nov; 139(44):2639-42. PubMed ID: 9842237
[TBL] [Abstract][Full Text] [Related]
36. [Hormone replacement therapy and the cardiovascular system: on the role of hemostasis].
Winkler UH
Zentralbl Gynakol; 1995; 117(10):510-5. PubMed ID: 7491833
[TBL] [Abstract][Full Text] [Related]
37. Postmenopausal estrogen and cardiovascular disease.
Stampfer MJ; Grodstein F; Bechtel S
Contemp Intern Med; 1994 Sep; 6(9):47-56, 59. PubMed ID: 10150308
[TBL] [Abstract][Full Text] [Related]
38. Hormone replacement therapy and coronary artery disease.
Morris D
Curr Opin Obstet Gynecol; 1996 Jun; 8(3):184-7. PubMed ID: 8818528
[TBL] [Abstract][Full Text] [Related]
39. The metabolic and cardiovascular consequences of HRT.
Stevenson JC
Br J Clin Pract; 1995; 49(2):87-90. PubMed ID: 7779651
[TBL] [Abstract][Full Text] [Related]
40. Hormone replacement therapy. Indications, benefits and risk.
Davis S
Aust Fam Physician; 1999 May; 28(5):437-45. PubMed ID: 10376367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
